Form 4 for ASTH Astrana Health, Inc.
Accepted 2024-08-14 00:00:00 ET · period of report 2024-08-13 · accession 0001104659-24-089694 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-14 | 2024-08-13 | ASTH | Dai, Weili | Dir | A - Grant | $0.00 | +3,564 | 7,214 | +98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-13 | A | A | 3,564 | $0.00 | 7,214 | D | — | — | (F1) Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders. (F2) Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders. |